-
February 20, 2013
Italy's Chiesi Farmaceutici has offered to buy the 40% stake in the USA's Cornerstone Therapeutics it does not already own
Full story
-
July 27, 2012
The US Food and Drug Administration (FDA) will approve fewer novel drugs in 2012 than it did last year, as the industry faces a number of ongoing operational risks, according to a new report.
Full story
-
November 18, 2011
The number of Medicare Part D drugs being covered by US prescription drug plans (PDPs) varies widely, and an increased share of the cost is being pushed to patients, a new study shows.
Full story
-
May 24, 2011
Expensive new drugs treating increasing numbers of patients could drive US drug spending by as much as 15% a year to 2013, say new forecasts.
Full story
-
April 07, 2011
Patients taking their prescription drugs as directed, and using generics, low-cost brands and home delivery wherever possible could reduce unnecessary spending on health care in the US by up to $403 billion a year, claims a new study.
Full story